File Download
  Patent History
  • Application
    US 11/375297 2006-03-14
  • Publication
    US 2008019911 2008-01-24
Supplementary

published patent: Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4

TitleMethod for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4
Priority Date2006-03-14 US 11/375297
2005-04-20 US 11/673091P
Inventors
Issue Date2008
Citation
US Published patent application US 2008019911. Washington, DC: US Patent and Trademark Office (USPTO), 2008 How to Cite?
AbstractAngiopoietin like protein 4 is a novel circulating protein predominantly expressed in adipose tissue and liver. Several recent studies demonstrated that angiopoietin like protein 4 is the target gene of peroxisome proliferation activators, the agonists of which are widely used as the anti-diabetic and lipid-lowering drugs. The invention provides a method for decreasing blood glucose or improving insulin sensitivity in a mammal in need thereof, comprising administering to the patient an amount of angiopoietin like protein-4 (ANGPTL4) polypeptide effective to decrease blood glucose, to improve glucose tolerance, or to increase insulin sensitivity.
Persistent Identifierhttp://hdl.handle.net/10722/176948

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:49Z-
dc.date.available2012-11-30T08:38:49Z-
dc.date.issued2008-
dc.identifier.citationUS Published patent application US 2008019911. Washington, DC: US Patent and Trademark Office (USPTO), 2008en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176948-
dc.description.abstractAngiopoietin like protein 4 is a novel circulating protein predominantly expressed in adipose tissue and liver. Several recent studies demonstrated that angiopoietin like protein 4 is the target gene of peroxisome proliferation activators, the agonists of which are widely used as the anti-diabetic and lipid-lowering drugs. The invention provides a method for decreasing blood glucose or improving insulin sensitivity in a mammal in need thereof, comprising administering to the patient an amount of angiopoietin like protein-4 (ANGPTL4) polypeptide effective to decrease blood glucose, to improve glucose tolerance, or to increase insulin sensitivity.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleMethod for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4en_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorXu, Aen_HK
dc.contributor.inventorLam, KSLen_HK
patents.identifier.applicationUS 11/375297en_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2008-01-24en_HK
patents.identifier.hkutechidMedi-2005-00189-1-
patents.date.application2006-03-14en_HK
patents.date.priority2006-03-14 US 11/375297en_HK
patents.date.priority2005-04-20 US 11/673091Pen_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 2008019911en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats